OPKO Health (OPK)
(Real Time Quote from BATS)
$1.20 USD
-0.03 (-2.44%)
Updated Apr 25, 2024 11:38 AM ET
4-Sell of 5 4
C Value D Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 96 | 153 | 135 | 72 | 85 |
Receivables | 123 | 127 | 260 | 286 | 135 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 66 | 74 | 87 | 132 | 53 |
Other Current Assets | 25 | 40 | 342 | 32 | 51 |
Total Current Assets | 309 | 395 | 823 | 523 | 324 |
Net Property & Equipment | 75 | 83 | 80 | 141 | 127 |
Investments & Advances | 16 | 28 | 11 | 16 | 21 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,339 | 1,419 | 842 | 1,156 | 1,201 |
Deposits & Other Assets | 204 | 204 | 600 | 600 | 597 |
Total Assets | 2,012 | 2,167 | 2,400 | 2,473 | 2,309 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 70 | 67 | 276 | 101 | 63 |
Current Portion Long-Term Debt | 27 | 37 | 0 | 25 | 10 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 90 | 98 | 0 | 241 | 165 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 43 | 0 | 0 |
Total Current Liabilities | 200 | 213 | 330 | 375 | 249 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 127 | 126 | 148 | 137 | 119 |
Convertible Debt | 214 | 210 | 188 | 222 | 211 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 27 | 27 | 15 | 37 | 88 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 622 | 606 | 715 | 802 | 695 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 8 | 8 | 7 | 7 | 7 |
Capital Surplus | 3,433 | 3,422 | 3,222 | 3,153 | 3,143 |
Retained Earnings | -2,012 | -1,823 | -1,512 | -1,482 | -1,511 |
Other Equity | -38 | -43 | -31 | -4 | -22 |
Treasury Stock | 2 | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | 1,389 | 1,562 | 1,685 | 1,672 | 1,615 |
Total Liabilities & Shareholder's Equity | 2,012 | 2,167 | 2,400 | 2,473 | 2,309 |
Total Common Equity | 1,389 | 1,562 | 1,685 | 1,672 | 1,615 |
Shares Outstanding | 773.20 | 772.60 | 681.30 | 670.00 | 665.60 |
Book Value Per Share | 1.80 | 2.02 | 2.47 | 2.49 | 2.43 |
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 96 | 139 | 108 | 111 |
Receivables | NA | 123 | 117 | 211 | 121 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 66 | 69 | 74 | 75 |
Other Current Assets | NA | 25 | 32 | 41 | 99 |
Total Current Assets | NA | 309 | 357 | 434 | 406 |
Net Property & Equipment | NA | 75 | 78 | 79 | 81 |
Investments & Advances | NA | 16 | 19 | 28 | 41 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1,339 | 1,353 | 1,380 | 1,401 |
Deposits & Other Assets | NA | 204 | 204 | 204 | 203 |
Total Assets | NA | 2,012 | 2,057 | 2,159 | 2,170 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 30 | 29 | 24 |
Accounts Payable | NA | 70 | 67 | 88 | 81 |
Current Portion Long-Term Debt | NA | 27 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 90 | 92 | 99 | 106 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 200 | 201 | 226 | 222 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 127 | 138 | 133 | 130 |
Convertible Debt | NA | 214 | 213 | 212 | 211 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 26 | 27 | 28 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 622 | 612 | 624 | 618 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 8 | 8 | 8 | 8 |
Capital Surplus | NA | 3,433 | 3,430 | 3,427 | 3,425 |
Retained Earnings | NA | -2,012 | -1,945 | -1,861 | -1,841 |
Other Equity | NA | -38 | -47 | -37 | -38 |
Treasury Stock | NA | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | NA | 1,389 | 1,445 | 1,535 | 1,552 |
Total Liabilities & Shareholder's Equity | NA | 2,012 | 2,057 | 2,159 | 2,170 |
Total Common Equity | 0 | 1,389 | 1,445 | 1,535 | 1,552 |
Shares Outstanding | 696.90 | 773.20 | 773.00 | 773.00 | 772.60 |
Book Value Per Share | 0.00 | 1.80 | 1.87 | 1.99 | 2.01 |